Biologics for severe asthma: deciphering what is best for the patient.

Journal: Expert review of clinical immunology
Published Date: Jun 30, 2025

Abstract

INTRODUCTION: Choosing the right biologic for the right patient is challenging. It requires evaluating patient characteristics and disease manifestations, understanding the scientific evidence supporting each biologic's efficacy and safety, and using a shared decision-making strategy with the patient.

Authors

  • Mario Cazzola
    Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Nicola A Hanania
    Section of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA. Electronic address: Hanania@bcm.edu.
  • Maria Gabriella Matera
    Unit of Pharmacology, Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
  • Paola Rogliani
    Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals